IRME (IR-Med) Asset Turnover: 0.00 (As of Jun. 2025)

What is IR-Med Asset Turnover?

IR-Med IRME Asset Turnover is 0.00 as of Jun. 2025. The stock has 1 warning sign investors should review.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. IR-Med's Revenue for the three months ended in Jun. 2025 was $0.00 Mil. IR-Med's Total Assets for the quarter that ended in Jun. 2025 was $0.15 Mil. Therefore, IR-Med's Asset Turnover for the quarter that ended in Jun. 2025 was 0.00.

Asset Turnover is linked to ROE % through Du Pont Formula. IR-Med's annualized ROE % for the quarter that ended in Jun. 2025 was 501.61%. It is also linked to ROA % through Du Pont Formula. IR-Med's annualized ROA % for the quarter that ended in Jun. 2025 was -1,875.59%.

IR-Med (OTCPK:IRME) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

IR-Med's annulized ROE % for the quarter that ended in Jun. 2025 is

	ROE %^**		(Q: Jun. 2025 )
=	Net Income	/	Total Stockholders Equity
=	-2.804	/	-0.559
=	(Net Income / Revenue)	*	(Revenue / Total Assets)	*	(Total Assets / Total Stockholders Equity)
=	(-2.804 / 0)	*	(0 / 0.1495)	*	(0.1495/ -0.559)
=	Net Margin %	*	Asset Turnover	*	Equity Multiplier
=	%	*	0	*	-0.2674
=	ROA %	*	Equity Multiplier
=	-1,875.59 %	*	-0.2674
=	501.61 %

Note: The Net Income data used here is four times the quarterly (Jun. 2025) net income data. The Revenue data used here is four times the quarterly (Jun. 2025) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

^** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

IR-Med's annulized ROA % for the quarter that ended in Jun. 2025 is

	ROA %		(Q: Jun. 2025 )
=	Net Income	/	Total Assets
=	-2.804	/	0.1495
=	(Net Income / Revenue)	*	(Revenue / Total Assets)
=	(-2.804 / 0)	*	(0 / 0.1495)
=	Net Margin %	*	Asset Turnover
=	%	*	0
=	-1,875.59 %

Note: The Net Income data used here is four times the quarterly (Jun. 2025) net income data. The Revenue data used here is four times the quarterly (Jun. 2025) revenue data.

Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.

IR-Med Asset Turnover Related Terms

IR-Med Asset Turnover Historical Data

* Premium members only.

The historical data trend for IR-Med's Asset Turnover can be seen below:

IR-Med Asset Turnover Chart

IR-Med Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Asset Turnover

0.00

IR-Med Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25
Asset Turnover	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

IRME vs SSKN, NUMD, WOK: Asset Turnover Comparison

For the Medical Devices subindustry, IR-Med's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IR-Med Asset Turnover vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, IR-Med's Asset Turnover distribution charts can be found below:

* The bar in red indicates where IR-Med's Asset Turnover falls into.

Save Embed

IR-Med Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

IR-Med's Asset Turnover for the fiscal year that ended in Dec. 2024 is calculated as

	Asset Turnover
=	Revenue	/	Average Total Assets
=	Revenue (A: Dec. 2024 )	/	( (Total Assets (A: Dec. 2023 )	+	Total Assets (A: Dec. 2024 ))	/ count )
=	0	/	( (0.999	+	0.251)	/ 2 )
=	0	/	0.625
=	0.00

IR-Med's Asset Turnover for the quarter that ended in Jun. 2025 is calculated as

	Asset Turnover
=	Revenue	/	Average Total Assets
=	Revenue (Q: Jun. 2025 )	/	( (Total Assets (Q: Mar. 2025 )	+	Total Assets (Q: Jun. 2025 ))	/ count )
=	0	/	( (0.124	+	0.175)	/ 2 )
=	0	/	0.1495
=	0.00

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →

What does a Asset Turnover of 0.00 mean?

IR-Med (IRME) has a Asset Turnover of 0.00 as of Jun. 2025. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on IR-Med and its competitors.

Is IR-Med's Asset Turnover too high?

IR-Med's current Asset Turnover is 0.00.

How does IR-Med's Asset Turnover compare to SSKN and NUMD?

IR-Med's Asset Turnover of 0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Asset Turnover for a Medical Devices & Instruments company?

A good Asset Turnover depends on the Medical Devices & Instruments industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Asset Turnover mean?

A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on IR-Med and its competitors. IR-Med's current Asset Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is IR-Med stock overvalued right now?

IR-Med (IRME) has a current Asset Turnover of 0.00. The current Asset Turnover is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Asset Turnover calculated?

Asset Turnover is calculated from a company's financial statements. For IR-Med (IRME), the current Asset Turnover is 0.00 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IR-Med Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies SSKN NUMD WOK ESMC PFSA ODYY NUWE BJDX VYCO VTAK ABT SYK MDT BSX EW XTER:SHL DXCM GEHC SZSE:300760 XAMS:PHIA

Address Z.H.R Industrial Zone, P.O. Box 143, Rosh Pina, ISR, 1231400

Website https://www.ir-medical.com

IR-Med Inc is a development-stage medical device company that is developing its technology through its Subsidiary and utilizing Infra-Red-light spectroscopy (IR) combined with Artificial Intelligence (AI) technology to develop non-invasive devices for various medical indications. These devices detect and measure biomarkers and molecules in blood and human tissue in real-time.